Evaluation of dysmenorrhea

Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017 Jul;39(7):585-95. Abstract

ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec (Re-affirmed 2021);132(6):1517-8.Full text  Abstract

Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020 Jan 21;323(3):268-9. Abstract

1. Fernández-Martínez E, Onieva-Zafra MD, Parra-Fernández ML. The impact of dysmenorrhea on quality of life among Spanish female university students. Int J Environ Res Public Health. 2019 Feb 27;16(5):713.Full text  Abstract

2. Iacovides S, Avidon I, Bentley A, et al. Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea. Acta Obstet Gynecol Scand. 2014 Feb;93(2):213-7.Full text  Abstract

3. Al-Jefout M, Seham AF, Jameel H, et al. Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol. 2015 Jun;28(3):173-85. Abstract

4. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21:762-78. Abstract

5. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134-1138. Abstract

6. Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017 Jul;39(7):585-95. Abstract

7. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104-13.Full text  Abstract

8. Latthe P, Latthe M, Say L, et al. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006 Jul 6;6:177.Full text  Abstract

9. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev. 1995;17(2):265-86. Abstract

10. Kennedy S. Primary dysmenorrhoea. Lancet. 1997 Apr 19;349(9059):1116. Abstract

11. Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG. 2010 Jan;117(2):185-92.Full text  Abstract

12. Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can. 2005;27:765-770. Abstract

13. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol. 1996;103:1134-42. Abstract

14. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 1990;97:588-594. Abstract

15. Chen CX, Draucker CB, Carpenter JS. What women say about their dysmenorrhea: a qualitative thematic analysis. BMC Womens Health. 2018 Mar 2;18(1):47.Full text  Abstract

16. Gray TG, Moores KL, James E, et al. Development and initial validation of an electronic personal assessment questionnaire for menstrual, pelvic pain and gynaecological hormonal disorders (ePAQ-MPH). Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:148-156. Abstract

17. ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec (Re-affirmed 2021);132(6):1517-8.Full text  Abstract

18. Hirsch M, Dhillon-Smith R, Cutner AS, et al. The prevalence of endometriosis in adolescents with pelvic pain: a systematic review. J Pediatr Adolesc Gynecol. 2020 Dec;33(6):623-30.Full text  Abstract

19. Dawood MY. Dysmenorrhea. Clin Obstet Gynecol. 1990;33:168-178. Abstract

20. Lumsden MA, Baird DT. Intra-uterine pressure in dysmenorrhea. Acta Obstet Gynecol Scand. 1985;64:183-186. Abstract

21. Altunyurt S, Göl M, Altunyurt S, et al. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med. 2005;50:251-255. Abstract

22. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428-441. Abstract

23. Lumsden MA, Kelly RW, Baird DT. Primary dysmenorrhoea: the importance of both prostaglandin E2 and F2 alpha. Br J Obstet Gynaecol. 1983;90:1135-1140. Abstract

24. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol. 1979;135:102-108. Abstract

25. Eden JA. Dysmenorrhea and premenstrual syndrome. In: Hacker NF, Moore JG, eds. Essentials of obstetrics and gynecology. 3rd edition. Philadelphia: WB Saunders; 1998.

26. Hedenberg-Magnusson B, Ernberg M, Alstergren P, et al. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Ondontol Scand. 2001;59:348-355. Abstract

27. Akerlund M, Stromberg P, Forsling ML. Primary dysmenorrhoea and vasopressin. Br J Obstet Gynaecol. 1979;86:484-487. Abstract

28. Liedman R, Hansson SR, Howe D, et al. Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation. Eur J Obstet Gynecol Reprod Biol. 2008;137:189-192. Abstract

29. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115:206-218. Abstract

30. Wong CL, Farquhar C, Roberts H, et al. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002120.Full text  Abstract

31. Marjoribanks J, Ayeleke RO, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul 30;(7):CD001751.Full text  Abstract

32. Low I, Wei SY, Lee PS, et al. Neuroimaging Studies of Primary Dysmenorrhea. Adv Exp Med Biol. 2018;1099:179-99. Abstract

33. Wu MH, Shoji Y, Chuang PC, et al. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med. 2007;9:1-20. Abstract

34. Nelson AL, Massoudi N. New developments in intrauterine device use: focus on the US. Open Access J Contracept. 2016;7:127-141.Full text  Abstract

35. Imai A, Matsunami K, Takagi H, et al. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clin Exp Obstet Gynecol. 2014;41(5):495-8. Abstract

36. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. Aug 2023 [internet publication].Full text

37. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001439.Full text  Abstract

38. Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother. 2008;9:2661-72. Abstract

39. Fothergill DJ. Common menstrual problems in adolescence. Arch Dis Child Educ Pract Ed. 2010;95:199-203. Abstract

40. Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020 Jan 21;323(3):268-9. Abstract

41. Saad Amer. Endometriosis. Obstetrics, Gynaecology and Reproductive Medicine. 2008;18:126-133.

42. Bettendorf B, Shay S, Tu F. Dysmenorrhea: contemporary perspectives. Obstet Gynecol Surv. 2008;63:597-603. Abstract

43. Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006;332:749-755.Full text  Abstract

44. Chapron C, Dubuisson JB, Pansini V, et al. Routine clinical examination is not sufficient for diagnosing and locating deeply infiltrating endometriosis. J Am Assoc Gynecol Laparosc. 2002;9:115-119. Abstract

45. Durain D. Primary dysmenorrhea: assessment and management update. J Midwifery Womens Health. 2004;49:520-528. Abstract

46. British Association for Sexual Health and HIV (BASHH). United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease. 2019 [internet publication].Full text

47. Howard FM. The role of laparoscopy as a diagnostic tool in chronic pelvic pain. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:467-94. Abstract

48. Goller JL, De Livera AM, Fairley CK, et al. Population attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data. Sex Transm Infect. 2016 Nov;92(7):525-31.Full text  Abstract

49. Price MJ, Ades AE, Welton NJ, et al. Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods. J Infect Dis. 2016 Aug 15;214(4):617-24.Full text  Abstract